The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Lorus Therapeutics

  • LOR
  • TSX
  • Consumer Products
  • Latest 0.47
  • Currency C$
  • Change 0.015
  • Percent Change 3.297 %
  • Volume 544,568
  • Wed Aug 27, 2014 03:59 PM EDT TSX data delayed 15 minutes.
Average recommendation
3 Analysts Reporting (Aug 26, 2014)
Strong Buy
Buy
Hold
Underperform
Sell
Change over time
Analyst rating breakdown
  Latest 4 weeks ago 2 months ago 3 months ago Last Year
Strong Buy 1 1 1 1
Buy 2 2 2 2
Hold 0 0 0 0
Underperform 0 0 0 0
Sell 0 0 0 0

As of Wed Aug 27, 2014 9:45 PM EDT
The consensus recommendation is the average buy, sell or hold rating for a company, based on a survey of brokerage equity analysts by Zacks Investment Research. We update the ratings daily.

Earnings & Estimates

Short Term
    Q1/13 Q2/13 Q3/13 Q4/13 Q1/14 Q2/14 Q3/14 Q4/14 Q1/15 Q2/15  

Actual quarterly earnings for the past eight quarters and estimated for the next two quarters

Estimated EPS ($)   -- -- -- -- -- -- -0.07 -0.06 -0.04 -0.04  
Actual EPS   -0.03 -0.04 -0.03 -0.03 -0.03 -0.06 -0.04 -0.04 -- --  
Surprise (%)   -- -- -- -- -- -- 42.9 33.3 -- --  
Est. % Chg from Prior Year   0.5 0.4 0.4 -1.6 -- -0.5 -0.3 -0.3 -33.3 33.3  
{#} Analysts   -- -- -- -- -- -- 1 2 2 2  
Date of Earnings   Oct 15 Jan 14 Apr 12 Jul 15 Oct 15 Jan 07 Apr 10 Jul 15 Oct 21 Jan 06  

Data provided by Zacks Investment Research.

Long Term
    2015 2016  

Estimated annual earnings for the next
two years

Estimated EPS ($)   -0.17 -0.18  
Actual EPS   -0.17 -0.17  
Surprise (%)   -- --  
Est. % Chg from Prior Year   -2.9 -2.9  
{#} Analysts   2 2  
Date of Earnings   -- --  

Trends & Revisions

Earnings Per Share Trend
  Current 7-Days Ago 30-Days Ago 60-Days Ago 90-Days Ago
  Mean Mean Mean Mean Mean
Current Quarter (ends Aug 2014) -0.04 -0.04 -0.04 -0.04 -0.04
Next Quarter (ends Nov 2014) -0.04 -0.04 -0.04 -0.04 -0.04
Current Fiscal Year (ends May 2015) -0.17 -0.17 -0.17 -0.17 -0.17
Next Fiscal Year (ends May 2016) -0.18 -0.18 -0.18 -0.18 -0.18

Data provided by Zacks Investment Research.

Earnings Revisions
Last 7 Days Last 30 Days
Up Revs Down Revs Up Revs Down Revs
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.